290 related articles for article (PubMed ID: 233166)
1. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
Pittman M
Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
[TBL] [Abstract][Full Text] [Related]
2. The concept of pertussis as a toxin-mediated disease.
Pittman M
Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
[TBL] [Abstract][Full Text] [Related]
3. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
Watanabe M
Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
[TBL] [Abstract][Full Text] [Related]
4. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
Robinson A; Irons LI
Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
[TBL] [Abstract][Full Text] [Related]
5. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.
Oda M; Cowell JL; Burstyn DG; Thaib S; Manclark CR
Infect Immun; 1985 Feb; 47(2):441-5. PubMed ID: 2857154
[TBL] [Abstract][Full Text] [Related]
7. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
Winsnes R; Lønnes T; Møgster B; Berdal BP
Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
[TBL] [Abstract][Full Text] [Related]
8. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin.
Zackrisson G; Taranger J; Trollfors B
J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488
[TBL] [Abstract][Full Text] [Related]
9. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
10. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
11. Serological correlates in whooping cough.
Granström M; Granström G
Vaccine; 1993; 11(4):445-8. PubMed ID: 8470429
[TBL] [Abstract][Full Text] [Related]
12. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.
Davis LE; Burstyn DG; Manclark CR
Pediatr Infect Dis; 1984; 3(5):448-51. PubMed ID: 6093068
[No Abstract] [Full Text] [Related]
13. [Pathogenetic significance of Bordetella pertussis toxin].
Finger H
Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
[No Abstract] [Full Text] [Related]
14. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
15. Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine.
Thomas MG; Ashworth LA; Miller E; Lambert HP
J Infect Dis; 1989 Nov; 160(5):838-45. PubMed ID: 2572651
[TBL] [Abstract][Full Text] [Related]
16. Acellular vaccines induce cell-mediated immunity to Bordetella pertussis antigens in infants undergoing primary vaccination against pertussis.
Ausiello CM; Urbani F; La Sala A; Lande R; Piscitelli A; Cassone A
Dev Biol Stand; 1997; 89():315-20. PubMed ID: 9272365
[TBL] [Abstract][Full Text] [Related]
17. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
18. Neutralizing antibodies to pertussis toxin in whooping cough.
Granström M; Granström G; Gillenius P; Askelöf P
J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752
[TBL] [Abstract][Full Text] [Related]
19. Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection.
Dolby JM; Stephens S
J Hyg (Lond); 1973 Mar; 71(1):193-207. PubMed ID: 4348456
[TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
